KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Restructuring Costs (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Restructuring Costs for 16 consecutive years, with $45.0 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Restructuring Costs fell 46.43% year-over-year to $45.0 million, compared with a TTM value of $231.0 million through Sep 2024, down 46.77%, and an annual FY2023 reading of $459.0 million, up 1019.51% over the prior year.
  • Restructuring Costs was $45.0 million for Q3 2024 at Thermo Fisher Scientific, down from $77.0 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $183.0 million in Q3 2023 and bottomed at $2.0 million in Q2 2022.
  • Average Restructuring Costs over 5 years is $53.7 million, with a median of $38.0 million recorded in 2020.
  • The sharpest move saw Restructuring Costs crashed 85.71% in 2022, then skyrocketed 5500.0% in 2023.
  • Year by year, Restructuring Costs stood at $32.0 million in 2020, then soared by 43.75% to $46.0 million in 2021, then grew by 19.57% to $55.0 million in 2022, then soared by 45.45% to $80.0 million in 2023, then crashed by 43.75% to $45.0 million in 2024.
  • Business Quant data shows Restructuring Costs for TMO at $45.0 million in Q3 2024, $77.0 million in Q2 2024, and $29.0 million in Q1 2024.